Transfusion and Apheresis Science
Volume 42, Issue 1 , Pages 53-61 , February 2010

In vivo tracking of transfused platelets for recovery and survival studies: An appraisal of labeling methods

References 

  1. Murphy S, Rebulla P, Bertolini F, Holme S, Moroff G, Snyder E, et al. In vitro assessment of the quality of stored platelet concentrates. The BEST (biomedical excellence for safer transfusion) task force of the International Society of Blood Transfusion. Transfus Med Rev. 1994;8:29–36
  2. Slichter SJ. Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients. J Clin Apher. 2006;21:78–84
  3. Blood Products Advisory Committee of the Food and Drug Administration. New standard for platelet evaluation; July 22, 2004.
  4. Murphy S. Radiolabeling of PLTs to assess viability: a proposal for a standard. Transfusion. 2004;44:131–133
  5. Taylor HL, Whitley P, Heaton A. A historical perspective on platelet radiolabeling techniques. Transfusion. 2006;46(Suppl. 3):53S–58S
  6. The Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Platelet radiolabeling procedure. Transfusion. 2006;46:59S–66S
  7. Heilmann E, Friese P, Anderson S, George JN, Hanson SR, Burstein SA, et al. Biotinylated platelets: a new approach to the measurement of platelet life span. Br J Haematol. 1993;85:729–735
  8. Ault KA, Knowles C. In vivo biotinylation demonstrates that reticulated platelets are the youngest platelets in circulation. Exp Hematol. 1995;23:996–1001
  9. Valeri CR, MacGregor H, Barnard MR, Summaria L, Michelson AD, Ragno G. Survival of baboon biotin-X-N-hydroxysuccinimide and (111)In-oxine-labelled autologous fresh and lyophilized reconstituted platelets. Vox Sang. 2005;88:122–129
  10. Stohlawetz P, Horvath M, Pernerstorfer T, Nguyen H, Vondrovec B, Robisch A, et al. Effects of nitric oxide on platelet activation during plateletpheresis and in vivo tracking of biotinylated platelets in humans. Transfusion. 1999;39:506–514
  11. Hughes DL, Evans G, Metcalfe P, Goodall AH, Williamson LM. Tracking and characterisation of transfused platelets by two colour, whole blood flow cytometry. Br J Haematol. 2005;130:791–794
  12. International Committee for Standardization in Hematology. Panel on diagnostic applications of radionuclides. Recommended method for indium-111 platelet survival studies. J Nucl Med. 1988;29:564–566
  13. Holme S, Heaton A, Roodt J. Concurrent label method with 111In and 51Cr allows accurate evaluation of platelet viability of stored platelet concentrates. Br J Haematol. 1993;84:717–723
  14. Louwes H, De Wolf JT, Houwerzijl E, Vellenga E. Evaluation assays measuring platelet kinetics in bone marrow and peripheral blood. An overview. Nucl Med Commun. 2002;23:581–590
  15. Van Reenen OR, Lötter MG, Minnaar PC, Heyns Adu P, Badenhorst PN, Pieters H. Radiation dose from human platelets labelled with indium 111. Br J Radiol. 1980;53:790–795
  16. Mettler FA, Huda W, Yoshizumi TT, Mahesh M. Effective doses in radiology and diagnostic nuclear medicine: a catalog. Radiology. 2008;248:254–263
  17. De Vries RA, de Bruin M, Oldenburg SJ, Zwiers A, Marx JJ, Poortman J, et al. A new dual-label technique for platelet survival studies with the use of 111indium and 114mindium tropolonate. Br J Haematol. 1991;78:236–241
  18. Badenhorst PN, Lötter MG, Heyns AD, van Reenen OR, Herbst C, Pieters H, et al. The influence of the ‘collection injury’ on the survival and distribution of indium-111-labeled canine platelets. Br J Haematol. 1982;52:233–240
  19. AuBuchon JP, Herschel L, Roger J, Murphy S. Preliminary validation of a new standard of efficacy for stored platelets. Transfusion. 2004;44:36–41
  20. AuBuchon JP, Herschel L, Roger J. Further evaluation of a new standard of efficacy for stored platelets. Transfusion. 2005;45:1143–1150
  21. Rand ML, Wang H, Mody M, Chu I, Treutiger I, Nguyen A, et al. Concurrent measurement of the survival of two populations of rabbit platelets labeled with either two PKH lipophilic dyes or two concentrations of biotin. Cytometry. 2002;47:111–117
  22. Odell TT, McDonald TP. Life span of mouse blood platelets. Proc Soc Exp Biol Med. 1961;106:107–108
  23. Jackson CW, Krance RA, Edwards CC, Whidden MA, Gauthier PA. Shortened platelet survival as a cause of thrombocytopenia in mice with L1210 leukemia. Cancer Res. 1980;40:667–670
  24. Barnard MR, MacGregor H, Ragno G, Pivacek LE, Khuri SF, Michelson AD, et al. Fresh, liquid-preserved, and cryopreserved platelets: adhesive surface receptors and membrane procoagulant activity. Transfusion. 1999;39:880–888
  25. Valeri CR, Macgregor H, Giorgio A, Ragno G. Comparison of radioisotope methods and a non-radioisotope method to measure platelet survival in the baboon. Transfus Apher Sci. 2005;32:275–281
  26. Mock DM, Lankford GL, Widness JA, Burmeister LF, Kahn D, Strauss RG. Measurement of circulating red cell volume using biotin-labeled red cells: validation against 51Cr-labeled red cells. Transfusion. 1999;39:149–155
  27. Mock DM, Lankford GL, Widness JA, Burmeister LF, Kahn D, Strauss RG. Measurement of red cell survival using biotin-labeled red cells: validation against 51Cr-labeled red cells. Transfusion. 1999;39:156–162
  28. Cowley H, Wojda U, Cipolone KM, Procter JL, Stroncek DF, Miller JL. Biotinylation modifies red cell antigens. Transfusion. 1999;39:163–168
  29. Cordle DG, Strauss RG, Lankford G, Mock DM. Antibodies provoked by the transfusion of biotin-labeled red cells. Transfusion. 1999;39:1065–1069
  30. Dale GL, Gaddy P, Pikul FJ. Antibodies against biotinylated proteins are present in normal human serum. J Lab Clin Med. 1994;123:365–371
  31. Magnusson S, Hou M, Hallberg EC, Breimer ME, Wadenvik H. Biotinylated platelets have an impaired response to agonists as evidenced by in vitro platelet aggregation tests. Thromb Res. 1998;89:53–58
  32. Mulder A, Kardol MJ, Niterink JGS, et al. Successful strategy for the large scale development of HLA-human monoclonal antibodies. In:  Charron D editors. Genetic diversity of HLA: functional and medical implications. vol. 2:Paris: EDK; 1997;p. 354–356
  33. Koene G, Mulder A, van der Ven K, Eijsink C, Franke M, Slootweg P, et al. Human monoclonal antibodies as a tool for the detection of HLA class I allele-specific expression loss in head-and-neck squamous cell carcinoma and corresponding lymph node metastases. Hum Immunol. 2006;67:692–699
  34. Lalezari P, Driscoll AM. Ability of thrombocytes to acquire HLA specificity from plasma. Blood. 1982;59:167–170
  35. Zeiler T, Heim M, Dempfle A, Kretschmer V. Platelets do not adsorb HLA class I molecules during storage of pooled platelet concentrates. Transfus Med. 2006;16:176–183
  36. Catalano PM, Smith JB, Murphy S. Platelet recovery from aspirin inhibition in vivo; differing patterns under various assay conditions. Blood. 1981;57:99–105
  37. Chamberlain KG, Tong M, Chiu E, Penington DG. The relationship of human platelet density to platelet age: platelet population labeling by monoamine oxidase inhibition. Blood. 1989;73:1218–1225
  38. Jacobs RM, Boyce JT, Kociba GJ. Flow cytometric and radioisotopic determinations of platelet survival time in normal cats and feline leukemia virus-infected cats. Cytometry. 1986;7:64–69
  39. Michelson AD, Barnard MR, Hechtman HB, MacGregor H, Connolly RJ, Loscalzo J, et al. In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci USA. 1996;93:11877–11882
  40. Dale GL. Platelet kinetics. Curr Opin Hematol. 1997;4:330–334
  41. Warner JB, Bruin EJ, Hannig H, Hellenkamp F, Hörning A, Mittmann K, et al. Use of sequence variation in three highly variable regions of the mitochondrial DNA for the discrimination of allogeneic platelets. Transfusion. 2006;46:554–561
  42. Slichter SJ. Evidence-based platelet transfusion guidelines. Hematol Am Soc Hematol Educ Program. 2007;172–178

PII: S1473-0502(09)00175-X

doi: 10.1016/j.transci.2009.10.007

Transfusion and Apheresis Science
Volume 42, Issue 1 , Pages 53-61 , February 2010